维普期刊资源整合服务平台（V6.5）

79篇 您的检索式：作者名="DELMAS P D"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Effects oforal chondroitin sulfate on the progression of knee osteoarthritis:apilot study显示文摘	UEBELHART D THONAR E J DELMAS P D	1998	Osteoarthritis Cartilage1998，6，：	1
2	Biochemical marker of bone turnover for the clinical assessment of metabolic bone disease 显示文摘	DELMAS P D	1990	Endocrinol Metab Clin North Am1990，19，：	1
3	How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? 显示文摘	DELMAS P D	2000	Bone2000，27，1：	1
4	Once-yearly zoledronic acid for treatment of post-menopausal osteoporosis显示文摘	Black DM Delmas PD Eastell R Reid IR Boonen S Cauley JA Cosman F Lakatos P Leung PC Man Z Mautalen C Mesenbrink P Hu H Caminis J Tong K Rosario-Jansen T Krasnow J Hue TF Sellmeyer D Eriksen EF Cummings SR HORIZON Pivotal Fracture Trial		0，，：	1
5	Resveratrol,a chemopreventive agent,disrupts the cell cycle control of human SW480 colorectal tumor cells显示文摘	Delmas D Passilly-Degrace P Jannin B	2002	Int J Mol Med2002，10，2：	1
6	The differing tempo of growth in bone size,mass,and density in girls is region-specific显示文摘	BASS S DELMAS P D PEARCE G		0，，06：	1
7	The use of biochemical markers of bone turnover in osteoporosis显示文摘	DELMAS P D EASTELL R GARNERO P	2000	Osteoporos Int2000，11，6：	1
8	Determination of biomass burning emission factors: Methods and results 显示文摘	Delmas R Laeaux J P Broeard D	1995	Environmental Monitoring and Assessment1995，，38：	1
9	Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs:some issues with meta-analyses显示文摘	DELMAS P D ZHENGQING L I COOPER C	2004	J Bone Miner Res2004，19，：	1
10	Once -yearly zoledronic acid for treatment of postmenopausal osteoporosis显示文摘	DELMAS P D BLACK D M PIERRE D	2007	N Engl J Med2007，356，18：	1
11	Effects of raloxifene on bone mineral density,serum cholesterol concentrations,and uterine endometrium in postmenopausal women显示文摘	Delmas P D Bjarnason N H Mitlak B H	1997	New Engl J Med1997，337，：	1
12	An immunoassay for type I collagen 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis显示文摘	GARNERO P DELMAS P D	2003	Bone2003，32，1：	1
13	Low serumIGF - 1 and occurrence of osteoporotic fractures in postmenopausal women(letter) 显示文摘	GARNERO P SORNAY RENDU E DELMAS P D	2000	Lancet2000，355，9207：	1
14	Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis 显示文摘	BLACK D M DELMAS P D EASTELL R	2007	N Engl J Med2007，356，18：	1
15	NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis显示文摘	Merle B Itzstein C Delmas P D	2003	J Cell Biochem2003，90，2：	1
16	Bone for mation rate in older normal women:Concurrent assessment with bone histomorphometry, calcium kinetics and biochemical markers显示文摘	EASTELL R DELMAS P D HODGSON S F	1988	J Clin Endocrinol Metab1988，67，：	1
17	Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis显示文摘	Black D Delmas P Eastell R	2007	N Engl J Med2007，356，18：	1
18	Biochemical markers of bone turover显示文摘	DELMAS P D	1993	Bone Miner Res1993，8，2：	1
19	A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover 显示文摘	Garnero P Darte C Delmas P D	1999	Bone1999，24，：	1
20	Strong bones in later life:luxury or necessity显示文摘	Delmas P D Fraser M	1999	Bull World Health Organ1999，77，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示